HJNO Sep/Oct 2019

Hospital Rounds responsibilities while also providing physician leadership and input into quality and safety ini- tiatives at Tulane Medical Center and Tulane Lake- side Hospital. “My initial interest in medicine was epidemi- ology and population health before my love of patient care brought me back to the bedside,” he said. “I’m excited about the opportunity to com- bine those interests in a role that allows me to interact with individual patients as well as have an impact on our patient population as a whole.” Mauldin received a medical degree from the Florida State University College of Medicine, as well as a master’s of health science from the Johns Hopkins Bloomberg School of Public Health. He completed his residency in internal medicine at Tulane University School of Medicine. TouroWelcomes Manuel Linares as Chief Executive Officer Touro announces Manuel “Manny” Linares as the new president and chief executive officer. He brings more than 30 years of healthcare lead- ership experience to Touro, New Orleans’ only the InterAmerican Society of Cardiology, execu- tive council. Ventura is board-certified in cardiology and holds a medical degree from the National Uni- versity School of Medicine in Buenos Aires, Argen- tina. Highlights from his medical training include a residency at the Central Military Hospital in Bue- nos Aires; an internship and residency at Ochsner, where he also completed fellowships in arterial hypertension and cardiovascular diseases; and a fellowship in heart failure and transplantation at Loyola University in Chicago, Ill. Ventura has served in his current position at Ochsner since 2000. Dr. BrandonMauldin Named Tulane Health System’s Chief Medical Officer Dr. Brandon Mauldin, an academic hospitalist at Tulane Medical Center and an assistant profes- sor of medicine at the Tulane University School of Medicine, will also serve as Tulane Health System’s chief medical officer.  Mauldin will maintain his clinical and academic whom round daily at the patient’s bedside. The team-based model focuses on the patient’s needs and goals of care of a particular nursing unit. This program is the first of its kind in Louisiana. “The ACU model has been a game changer at STPH.” said Michael K. Hill, MD, STQN med- ical director. “This is a team-based model that includes the patient and their families in the care they receive both in the hospital and after dis- charge. The ACU has already resulted in improved patient satisfaction score, decreased length of stay, and reduced patient readmissions.” Kathy Felps, DNSc, RN, director of nursing at STPH, was instrumental for proposing and spear- heading the ACU model and has been with STPH three years. Landers, head of hospital medicine, has been on the staff of STPH for 20 years. Illie is a hospitalist who is currently chair of medical ser- vices at STPH and has been on the medical staff for 11 years. Baier has been involved in the read- mission reduction program at STPH and has been a hospitalist at STPH for seven years. Ochsner Cardiologist Receives International Impact Award Hector O. Ventura, MD, FACC, FACP – sec- tion head, cardiomyopathy and heart trans- plantation, John Ochsner Heart and Vascular Institute (JOHVI) – has been recognized by the American Heart Association / American Stroke Association (AHA/ASA) with the 2019 Ron Had- dock AHA/ASA International Impact Award. Awarded annually, this honor recognizes an indi- vidual or group of individuals for outstanding con- tributions, which have advanced AHA/ASA inter- national goals. Recipients are recognized as a leader or major contributor in an activity, enter- prise, or program of the AHA at the international level. Ventura was recognized with this honor dur- ing the annual AHA/ASA awards luncheon this June in Plano, Tex. Ventura holds more than 35 years’ experience in healthcare and currently serves on the AHA Inter- national Committee. He has volunteered exten- sively to leading international initiatives focused on distance learning and equity in care, includ- ing the Coalition to Reduce Racial and Ethnic Disparities in Cardiovascular Disease Outcomes (CREDO). Additionally, he is a past AHA/ACC vice president, United States representative, to Hector O. Ventura, MD, FACC, FACP – section head, cardiomyopathy and heart transplantation, John Ochsner Heart and Vascular Institute (JOHVI) – has been recognized by the American Heart Association / American Stroke Association (AHA/ASA) with the 2019 Ron Haddock AHA/ASA International Impact Award. Ventura is shown accepting the award during the annual AHA/ASA awards luncheon this June in Plano, Tex. 62 SEP / OCT 2019  I  Healthcare Journal of NEW ORLEANS